Regeneron Pharmaceuticals, Inc.
REGN NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 30, 2026
ET
EPS Est.
10.16
EPS Actual
14.29
Revenue Est.
$3.82B
Revenue Actual
$4.29B
Next Earnings Report
Date
Oct 28, 2026 · Wed
ET Oct 28, 2026 · Wed
Time
10/28 10:00-13:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
15.99
Revenue Est.
$4.54B
Company Overview
Regeneron Pharmaceuticals, Inc. (ticker REGN) is listed on NASDAQ with a market cap of about $75.74B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), Pre-market, with consensus EPS of 15.99. In the last 15 reported quarters, EPS beat consensus estimates 13 times.
Actual EPS TrendRecently15Term · Feb 3, 2023 → Jul 30, 2026
Feb 3, 2023Range: 8.22 ~ 14.29Jul 30, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 30, 2026 | -- | 10.16 | Above forecast↑14.29 | $3.82B | $4.29B |
| Apr 29, 2026 | -- | 8.91 | Above forecast↑9.47 | $3.48B | $3.61B |
| Jan 30, 2026 | -- | 10.74 | Above forecast↑11.44 | $3.81B | $3.88B |
| Oct 28, 2025 | -- | 9.65 | Above forecast↑11.83 | $3.59B | $3.75B |
| Aug 1, 2025 | -- | 8.43 | Above forecast↑12.89 | $3.29B | $3.68B |
| Apr 29, 2025 | -- | 8.62 | Below forecast↓8.22 | $3.25B | $3.03B |
| Feb 4, 2025 | -- | 11.21 | Above forecast↑12.07 | $3.74B | $3.79B |
| Oct 31, 2024 | -- | 11.69 | Above forecast↑12.46 | $3.67B | $3.72B |
| Aug 1, 2024 | -- | 10.61 | Above forecast↑11.56 | $3.38B | $3.55B |
| May 2, 2024 | -- | 10.17 | Below forecast↓9.55 | $3.23B | $3.15B |
| Feb 2, 2024 | -- | 10.73 | Above forecast↑11.86 | $3.29B | $3.43B |
| Nov 2, 2023 | -- | 10.72 | Above forecast↑11.59 | $3.22B | $3.36B |
| Aug 3, 2023 | -- | 9.84 | Above forecast↑10.24 | $3.02B | $3.16B |
| May 4, 2023 | -- | 9.25 | Above forecast↑10.09 | $3B | $3.16B |
| Feb 3, 2023 | -- | 10.03 | Above forecast↑12.56 | $3.12B | $3.41B |
Original Filings (SEC)
Quarterly10-Q · 2026-07-30 ↗
Earnings Release8-K · 2026-07-30 ↗
Quarterly10-Q · 2026-04-29 ↗
Earnings Release8-K · 2026-04-29 ↗
Annual10-K · 2026-02-04 ↗
Earnings Release8-K · 2026-01-30 ↗
Quarterly10-Q · 2025-10-28 ↗
Earnings Release8-K · 2025-10-28 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
